7-hydroxy Methotrexate (sodium salt)
如果您对该产品感兴趣的话,可以
产品名称:
7-hydroxy Methotrexate (sodium salt)
产品型号:
GOY-Y0447
产品展商:
谷研
产品文档:
无相关文档
发布时间:2023-04-10
简单介绍
7-hydroxy Methotrexate (sodium salt)3mg/mL in DMSO, 14mg/mL in DMF
7-hydroxy Methotrexate (sodium salt)
的详细介绍
性能参数
|
产品名称
|
7-hydroxy Methotrexate (sodium salt)
|
规格
|
500μg 1mg
|
货号
|
GOY-Y0447
|
含量
|
>96.00%
|
CAS
|
N/A
|
别名
|
7-hydroxy MTX
|
|
|
化学名
|
N-[4-[[(2,4-diamino-7,8-dihydro-7-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid, trisodium salt
|
分子式
|
C20H22N8O6?3Na
|
分子量
|
分子 539.4
|
溶解度
|
3mg/mL in DMSO, 14mg/mL in DMF
|
储存条件
|
Store at 4°C
|
General tips
|
|
用途
|
仅供科研
|
价格
|
电询
|
|
详细内容
|
7-hydroxy Methotrexate (7-hydroxy MTX) is a phase I metabolite of MTX, which is converted by hepatic aldehyde oxidases.[1] Elimination of 7-hydroxy MTX is associated with the multi-drug transporters Abcc2, Abcc3, and Abcg2 in transgenic mouse models. It and the parent compound rapidly accumulate when all three transporters are absent.[2] Formulations containing methotrexate have been used in the treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions.[3],[4] Various methods have been described to quantify 7-hydroxy MTX levels during cancer therapy to avoid toxicity.[5],[6]
|
公司正在销售的产品:
尿囊素 规格: HPLC≥99%;20mg
1,2,3,4,6-O-没食子酰葡萄糖 规格: HPLC≥99%;20mg
雷酚内酯 规格: HPLC≥99%;20mg
L-羟脯氨酸 规格: HPLC≥98%;100mg
L-精氨酸 规格: HPLC≥98%;200mg
加兰他敏 规格: HPLC≥98%;20mg
|
甘氨酸钠Glycine sodium,98%6000-44-825G
油酸钠Sodium oleate,≥99%143-19-1250MG
氨基钠Sodium amide,95%7782-92-525G
氟化氢钠Sodium hydrogen difluoride,98%1333-83-1250G
4-氨基苯甲酸钠4-Aminobenzoic acid sodium salt,≥99%555-06-625G
十二烷基苯磺酸钠Sodium dodecylbenzenesulfonate25155-30-0100G
|